|
|
|
Size
|
Re: Oxford CEBM paper on mortality CoVID-19
|
Rod Jackson |
Tue, 31 Mar 2020 22:10:45 +0000 |
1131 lines |
Re: Ioannidis paper on CoVID-19
|
David Richard Leslie Cawthorpe |
Tue, 31 Mar 2020 21:53:36 +0000 |
898 lines |
Re: Oxford CEBM paper on mortality CoVID-19
|
Rod Jackson |
Tue, 31 Mar 2020 21:50:25 +0000 |
988 lines |
Re: Ioannidis paper on CoVID-19
|
Anoop B |
Tue, 31 Mar 2020 17:45:45 -0400 |
1231 lines |
Re: Ioannidis paper on CoVID-19
|
Barry Diner |
Tue, 31 Mar 2020 16:07:15 -0500 |
1196 lines |
Re: Oxford CEBM paper on mortality CoVID-19
|
Kelleher, Kevin |
Tue, 31 Mar 2020 20:56:15 +0000 |
1009 lines |
Re: Ioannidis paper on CoVID-19
|
Gerd Antes |
Tue, 31 Mar 2020 22:53:51 +0200 |
358 lines |
Re: Oxford CEBM paper on mortality CoVID-19
|
Kelleher, Kevin |
Tue, 31 Mar 2020 20:49:54 +0000 |
936 lines |
Re: Oxford CEBM paper on mortality CoVID-19
|
Carlos A. |
Tue, 31 Mar 2020 17:49:03 -0300 |
1312 lines |
Re: Oxford CEBM paper on mortality CoVID-19
|
Rod Jackson |
Tue, 31 Mar 2020 20:40:36 +0000 |
939 lines |
Re: Ioannidis paper on CoVID-19
|
Bill Cayley, Jr |
Tue, 31 Mar 2020 18:56:15 +0000 |
1041 lines |
Re: Oxford CEBM paper on mortalaity CoVID-19
|
Myles, Nickolas [PH] |
Tue, 31 Mar 2020 18:54:59 +0000 |
879 lines |
Re: [nmamembers2012] STUFF on CoVID-19
|
Moacyr Roberto Cuce Nobre |
Tue, 31 Mar 2020 12:57:50 -0300 |
911 lines |
Re: Ioannidis paper on CoVID-19
|
Benjamin Djulbegovic MD |
Tue, 31 Mar 2020 15:36:32 +0000 |
662 lines |
Re: [nmamembers2012] STUFF on CoVID-19
|
Chuck A. Simpson |
Tue, 31 Mar 2020 14:23:48 +0000 |
1179 lines |
Re: [nmamembers2012] STUFF on CoVID-19
|
joseph ana |
Tue, 31 Mar 2020 12:47:31 +0000 |
863 lines |
Virtual academic, not live, conference - Business & Economics
|
Helen Kantarelis |
Tue, 31 Mar 2020 08:33:01 -0400 |
77 lines |
Re: Ioannidis paper on CoVID-19
|
David Richard Leslie Cawthorpe |
Tue, 31 Mar 2020 12:27:11 +0000 |
511 lines |
Re: Ioannidis paper on CoVID-19
|
Carl Heneghan |
Tue, 31 Mar 2020 13:14:52 +0100 |
545 lines |
Re: Ioannidis paper on CoVID-19
|
Oleg Borisenko |
Tue, 31 Mar 2020 11:45:39 +0200 |
532 lines |
Re: Ioannidis paper on CoVID-19
|
joseph ana |
Tue, 31 Mar 2020 09:39:48 +0000 |
527 lines |
Re: Ioannidis paper on CoVID-19
|
Dr Amy Price |
Tue, 31 Mar 2020 00:06:04 -0400 |
354 lines |
Re: Ioannidis paper on CoVID-19
|
Anoop B |
Mon, 30 Mar 2020 23:24:39 -0400 |
206 lines |
keeping perspective
|
Bewley, Susan |
Tue, 31 Mar 2020 02:55:36 +0000 |
403 lines |
Re: Ioannidis paper on CoVID-19
|
Ogston, Jena |
Mon, 30 Mar 2020 19:24:10 -0500 |
173 lines |
CoVID-19 tracking graphic with multiple countries at a glance...
|
David Richard Leslie Cawthorpe |
Mon, 30 Mar 2020 23:30:54 +0000 |
51 lines |
Re: Ioannidis paper on CoVID-19
|
Anoop B |
Mon, 30 Mar 2020 18:32:43 -0400 |
113 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Huw Llewelyn [hul2] |
Mon, 30 Mar 2020 22:26:32 +0000 |
351 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Rod Jackson |
Mon, 30 Mar 2020 21:50:05 +0000 |
219 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
McCormack, James |
Mon, 30 Mar 2020 21:44:03 +0000 |
193 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Benjamin Djulbegovic MD |
Mon, 30 Mar 2020 21:36:14 +0000 |
327 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Rod Jackson |
Mon, 30 Mar 2020 21:28:14 +0000 |
314 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Dr Amy Price |
Mon, 30 Mar 2020 17:22:18 -0400 |
366 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Bill Cayley, Jr |
Mon, 30 Mar 2020 21:18:19 +0000 |
275 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Jon Brassey |
Mon, 30 Mar 2020 22:18:06 +0100 |
238 lines |
Re: COVID-19 Rapid Review - hydroxychloroquine (plus an added comment on false negative tests)
|
Rod Jackson |
Mon, 30 Mar 2020 21:13:43 +0000 |
151 lines |
Re: Masks on or off?
|
Benjamin Djulbegovic MD |
Mon, 30 Mar 2020 18:43:46 +0000 |
260 lines |
Masks on or off?
|
Tom Jefferson |
Mon, 30 Mar 2020 19:00:10 +0200 |
98 lines |
COVID-19 Rapid Review - hydroxychloroquine
|
McCormack, James |
Mon, 30 Mar 2020 16:44:45 +0000 |
90 lines |
33 online research methods / data analytics courses
|
Geoffrey Hubona |
Sun, 29 Mar 2020 16:09:13 -0700 |
25 lines |
Ioannidis paper on CoVID-19
|
David Richard Leslie Cawthorpe |
Sun, 29 Mar 2020 14:50:57 +0000 |
65 lines |
Re: Communicating negative results for COVID-19?
|
Kelleher, Kevin |
Sun, 29 Mar 2020 10:31:35 +0000 |
564 lines |
Re: Communicating negative results for COVID-19?
|
Donald E. Stanley |
Sun, 29 Mar 2020 10:02:47 +0000 |
120 lines |
Re: Communicating negative results for COVID-19?
|
Huw Llewelyn [hul2] |
Sun, 29 Mar 2020 09:15:18 +0000 |
177 lines |
Re: Communicating negative results for COVID-19?
|
David Richard Leslie Cawthorpe |
Sat, 28 Mar 2020 20:56:58 +0000 |
124 lines |
Communicating negative results for COVID-19?
|
Shaughnessy, Allen |
Sat, 28 Mar 2020 16:02:17 -0400 |
106 lines |
Re: mGAP WHO Covid-19 mental health resources
|
Craig Lockwood |
Sat, 28 Mar 2020 03:04:19 +0000 |
217 lines |
mGAP WHO Covid-19 mental health resources
|
David Richard Leslie Cawthorpe |
Sat, 28 Mar 2020 02:37:37 +0000 |
128 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Benjamin Djulbegovic MD |
Fri, 27 Mar 2020 22:39:17 +0000 |
607 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
McCormack, James |
Fri, 27 Mar 2020 22:14:45 +0000 |
288 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Su May |
Sat, 28 Mar 2020 05:54:49 +0800 |
328 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Bill Cayley, Jr |
Fri, 27 Mar 2020 21:52:31 +0000 |
175 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Huw Llewelyn [hul2] |
Fri, 27 Mar 2020 21:47:58 +0000 |
50 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Huw Llewelyn [hul2] |
Fri, 27 Mar 2020 21:44:18 +0000 |
328 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Shaughnessy, Allen |
Fri, 27 Mar 2020 17:25:05 -0400 |
332 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Huw Llewelyn [hul2] |
Fri, 27 Mar 2020 21:22:10 +0000 |
193 lines |
Estimating affected population by COVID19
|
beatrice muraguri |
Fri, 27 Mar 2020 16:11:59 +0000 |
89 lines |
COVD-19: Can population exposure be estimated from the death rate?
|
David Richard Leslie Cawthorpe |
Fri, 27 Mar 2020 14:05:45 +0000 |
55 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Baijayanta Mukhopadhyay |
Fri, 27 Mar 2020 09:50:53 -0400 |
67 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Anoop B |
Thu, 26 Mar 2020 23:16:41 -0400 |
605 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Benjamin Djulbegovic MD |
Fri, 27 Mar 2020 01:01:30 +0000 |
441 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Huw Llewelyn [hul2] |
Thu, 26 Mar 2020 23:56:59 +0000 |
308 lines |
Re: Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Benjamin Djulbegovic MD |
Thu, 26 Mar 2020 22:58:31 +0000 |
114 lines |
Probability of Covid-19 virus PCR +ve conditional on upper respiratory tract symptoms
|
Huw Llewelyn [hul2] |
Thu, 26 Mar 2020 18:34:21 +0000 |
50 lines |
Webinars on COVID-19 and doing fieldwork
|
Silvana di Gregorio |
Thu, 26 Mar 2020 14:19:22 +0000 |
69 lines |
CoVID-19 spread model out of Oxford
|
David Richard Leslie Cawthorpe |
Thu, 26 Mar 2020 12:47:17 +0000 |
61 lines |
Re: Country wise Age Distribution Covid Deaths-Data?
|
Michael Power |
Wed, 25 Mar 2020 16:06:25 +0000 |
225 lines |
Country wise Age Distribution Covid Deaths-Data?
|
Dr Danish Ahmad |
Thu, 26 Mar 2020 01:55:07 +1100 |
358 lines |
Need to conference call globally about the COVID-19 pandemic?
|
David Richard Leslie Cawthorpe |
Wed, 25 Mar 2020 05:57:13 +0000 |
59 lines |
Interactive interface representing COVID-19 Global cases
|
David Richard Leslie Cawthorpe |
Wed, 25 Mar 2020 05:48:44 +0000 |
49 lines |
Re: COVID-19 and high quality evidence
|
Manitoba Hunter |
Tue, 24 Mar 2020 20:51:00 +0000 |
414 lines |
Re: COVID-19 and high quality evidence
|
Orkan Okan |
Tue, 24 Mar 2020 21:25:03 +0100 |
218 lines |
Re: COVID-19 and high quality evidence
|
Jon Brassey |
Tue, 24 Mar 2020 20:14:35 +0000 |
179 lines |
Re: COVID-19 and high quality evidence
|
Craig Lockwood |
Tue, 24 Mar 2020 20:11:34 +0000 |
162 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Dr Amy Price |
Tue, 24 Mar 2020 15:56:46 -0400 |
112 lines |
COVID-19 and high quality evidence
|
Jon Brassey |
Tue, 24 Mar 2020 18:23:12 +0000 |
60 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Dr Amy Price |
Tue, 24 Mar 2020 14:00:23 -0400 |
138 lines |
Covid-19 Tracking and informational model to consider
|
David Richard Leslie Cawthorpe |
Tue, 24 Mar 2020 13:20:06 +0000 |
67 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Myles, Nickolas [PH] |
Mon, 23 Mar 2020 20:15:19 +0000 |
293 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Benjamin Djulbegovic MD |
Mon, 23 Mar 2020 19:59:07 +0000 |
226 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Myles, Nickolas [PH] |
Mon, 23 Mar 2020 19:45:09 +0000 |
83 lines |
Re: COVID19 individual patient database ...
|
Benjamin Djulbegovic MD |
Mon, 23 Mar 2020 18:09:37 +0000 |
310 lines |
Re: COVID19 individual patient database ...
|
Vivek Podder |
Mon, 23 Mar 2020 23:41:11 +0600 |
212 lines |
COVID-19 - "the day after" China suspended the isolation measures
|
Lelia Carvalho |
Mon, 23 Mar 2020 13:59:45 -0300 |
58 lines |
Re: COVID19 individual patient database ...
|
Rakesh Biswas |
Mon, 23 Mar 2020 21:49:23 +0530 |
143 lines |
COVID19 individual patient database ...
|
Benjamin Djulbegovic MD |
Mon, 23 Mar 2020 14:21:14 +0000 |
49 lines |
Re: Advice for taking an evidence-based approach to COVID-19 research
|
Neal Maskrey |
Mon, 23 Mar 2020 07:29:33 +0000 |
568 lines |
Re: Advice for taking an evidence-based approach to COVID-19 research
|
Mohammed T. Ansari |
Sun, 22 Mar 2020 22:03:53 -0400 |
349 lines |
Re: Investigating Overdiagnosis and Overtreatment
|
Carlos A. |
Sun, 22 Mar 2020 20:00:27 -0300 |
446 lines |
Re: Advice for taking an evidence-based approach to COVID-19 research
|
Shadia Constantine |
Mon, 23 Mar 2020 07:53:03 +0900 |
292 lines |
Re: Advice for taking an evidence-based approach to COVID-19 research
|
Benjamin Djulbegovic MD |
Sun, 22 Mar 2020 21:42:38 +0000 |
427 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Dr Amy Price |
Sun, 22 Mar 2020 14:49:54 -0400 |
78 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Barry Diner |
Sun, 22 Mar 2020 12:09:02 -0500 |
320 lines |
Paper Invitation for Special Issue "Applied Medical Statistics: Theory, Computation, Applicability"
|
Polychronis Kostoulas |
Sun, 22 Mar 2020 16:41:39 +0000 |
226 lines |
Advice for taking an evidence-based approach to COVID-19 research
|
Shaughnessy, Allen |
Sun, 22 Mar 2020 12:11:38 -0400 |
242 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
David Richard Leslie Cawthorpe |
Sun, 22 Mar 2020 15:16:16 +0000 |
195 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Mohammed T. Ansari |
Sun, 22 Mar 2020 11:09:33 -0400 |
181 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Jeremy Howick |
Sun, 22 Mar 2020 14:46:56 +0000 |
164 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Anoop B |
Sun, 22 Mar 2020 10:25:53 -0400 |
148 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Benjamin Djulbegovic MD |
Sun, 22 Mar 2020 13:51:43 +0000 |
55 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Michael Power |
Sun, 22 Mar 2020 08:43:32 +0000 |
433 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
David Richard Leslie Cawthorpe |
Sat, 21 Mar 2020 22:08:52 +0000 |
161 lines |
Re: German pulmonologist's important commentary on coronavirus-19
|
Michael Power |
Sat, 21 Mar 2020 19:21:36 +0000 |
156 lines |
German pulmonologist's important commentary on coronavirus-19
|
David Richard Leslie Cawthorpe |
Sat, 21 Mar 2020 17:16:19 +0000 |
62 lines |
Re: Investigating Overdiagnosis and Overtreatment
|
Benjamin Djulbegovic MD |
Sat, 21 Mar 2020 15:15:26 +0000 |
256 lines |
Investigating Overdiagnosis and Overtreatment
|
Vivek Podder |
Sat, 21 Mar 2020 18:56:36 +0600 |
84 lines |
Re: RE best evidence for primary care doctors and GPs especially in LMIC
|
Jon Brassey |
Fri, 20 Mar 2020 06:05:26 +0000 |
187 lines |
Re: RE best evidence for primary care doctors and GPs especially in LMIC
|
Su May |
Fri, 20 Mar 2020 08:08:49 +0800 |
166 lines |
RE best evidence for primary care doctors and GPs especially in LMIC
|
Kumara Mendis |
Fri, 20 Mar 2020 05:32:50 +0530 |
131 lines |
Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online
|
Benjamin Djulbegovic MD |
Thu, 19 Mar 2020 14:37:11 +0000 |
376 lines |
Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online
|
Homa Keshavarz |
Thu, 19 Mar 2020 10:35:11 -0400 |
461 lines |
Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online
|
Benjamin Djulbegovic MD |
Thu, 19 Mar 2020 14:20:13 +0000 |
270 lines |
Re: OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online
|
usman khan |
Thu, 19 Mar 2020 12:02:15 +0000 |
258 lines |
OFFICIAL: FOR INFO: PHE daily COVID-19 Evidence Briefings online
|
Caroline DeBrun |
Thu, 19 Mar 2020 10:27:38 +0000 |
228 lines |
COVID 19→Bibliometric Dashboard with Altmetric Data (New Version)
|
Ernesto Barrera |
Thu, 19 Mar 2020 08:01:55 +0100 |
108 lines |
Adjuvant-containing control arms in pivotal quadrivalent human papillomavirus vaccine trials: restoration of previously unpublished methodology
|
Tom Jefferson |
Wed, 18 Mar 2020 08:53:08 +0100 |
152 lines |
Re: Evidence & COVID 19
|
David Nunan |
Thu, 12 Mar 2020 09:55:14 +0000 |
320 lines |
Re: Tom Jefferson: Covid 19—we live in surreal times
|
Wouter Havinga |
Wed, 11 Mar 2020 22:36:42 +0000 |
19 lines |
Re: Tom Jefferson: Covid 19—we live in surreal times
|
Wouter Havinga |
Wed, 11 Mar 2020 22:29:32 +0000 |
66 lines |
Re: Evidence & COVID 19
|
Ernesto Barrera |
Wed, 11 Mar 2020 12:35:27 +0100 |
204 lines |
Re: Evidence & COVID 19
|
Tom Jefferson |
Wed, 11 Mar 2020 12:00:17 +0100 |
67 lines |
Re: Evidence & COVID 19
|
David Nunan |
Wed, 11 Mar 2020 09:40:30 +0000 |
245 lines |
Applications open for the only MRes OR Prof Doc in Occupational Health, Psychology and Management
|
Raluca Matei |
Sat, 7 Mar 2020 20:03:21 +0000 |
501 lines |
Re: Evidence & COVID 19
|
Tom Jefferson |
Fri, 6 Mar 2020 22:37:00 +0100 |
217 lines |
Evidence & COVID 19
|
David Nunan |
Fri, 6 Mar 2020 19:15:12 +0000 |
146 lines |
Scoping Reviews
|
Craig Lockwood |
Thu, 5 Mar 2020 21:33:00 +0000 |
177 lines |
Tom Jefferson: Covid 19—we live in surreal times
|
Tom Jefferson |
Thu, 5 Mar 2020 17:03:08 +0100 |
52 lines |
Re: Is this a trial?
|
Anoop B |
Tue, 3 Mar 2020 18:14:09 -0500 |
1440 lines |
Key paper on validity of new MCAT
|
David Richard Leslie Cawthorpe |
Mon, 2 Mar 2020 17:39:08 +0000 |
69 lines |
Covid 19—many questions, no clear answers
|
Tom Jefferson |
Mon, 2 Mar 2020 18:37:41 +0100 |
63 lines |
Applications open for the only MRes OR Prof Doc in Occupational Health, Psychology and Management
|
Raluca Matei |
Sun, 1 Mar 2020 21:50:18 +0000 |
375 lines |